Literature DB >> 3495798

Isolation of a T-cell clone that reacts with both antigen and anti-idiotype: evidence for anti-idiotype as internal image for antigen at the T-cell level.

R Singhai, J G Levy.   

Abstract

T-cell lines were derived from ferredoxin nonresponder B10.D2 mice that share an idiotype expressed by a monoclonal antibody (Fd-B2) with specificity for one of the two major antigenic determinants (the C determinant) of the antigen. The T-cell line and T-cell clones derived from it release interleukin 2 not only in the presence of anti-Fd-B2 idiotype antibody but in the presence of ferredoxin. The line was shown to be major histocompatibility complex-restricted in that it would respond to the anti-idiotype and antigen only in the context of presentation by cells of the H-2d haplotype. This observation also establishes that the nonresponder status of H-2d animals cannot be attributed to a lesion at the level of antigen presentation. Analysis of the fine specificity of one idiotypic clone showed that it responded only to the anti-idiotype or products of the antigen containing the C determinant, since enzymatically degraded peptides devoid of this determinant did not stimulate these cells. Furthermore, it was found that presentation of both the antigen and the anti-idiotype to the specific clone could be blocked by the Fd-B2 monoclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495798      PMCID: PMC304971          DOI: 10.1073/pnas.84.11.3836

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  T-cell growth factor-mediated T-cell proliferation.

Authors:  K A Smith; S Gillis; P E Baker; D McKenzie; F W Ruscetti
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

2.  Recognition of idiotypes in lymphocyte interactions. II. Antigen-independent cooperation between T and B lymphocytes that possess similar and complementary idiotypes.

Authors:  K Eichmann; I Falk; K Rajewsky
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

3.  Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells.

Authors:  J T Nepom; H L Weiner; M A Dichter; M Tardieu; D R Spriggs; C F Gramm; M L Powers; B N Fields; M I Greene
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

4.  Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase.

Authors:  A B Schreiber; P O Couraud; C Andre; B Vray; A D Strosberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

5.  Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.

Authors:  E L Reinherz; C Morimoto; K A Fitzgerald; R E Hussey; J F Daley; S F Schlossman
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  Fine specificity of antigen recognition by T cell hybridoma clones specific for poly-18: a synthetic polypeptide antigen of defined sequence and conformation.

Authors:  A Fotedar; M Boyer; W Smart; J Widtman; E Fraga; B Singh
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Genetic control of the immune response to ferredoxin: linkage and mapping of T cell proliferation and antibody production genes to the MHC of mice.

Authors:  L K Sikora; J G Levy
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

9.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

10.  Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation.

Authors:  M Kimoto; C G Fathman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.